Abstract
Novel inhibitors of pyroptosis promise breakthroughs in treating inflammatory diseases and malignant tumors. In this issue of Cell Chemical Biology, Hu et al.1 identify two repurposed drugs that selectively target gasdermin D (GSDMD) oligomers, effectively suppressing pyroptosis while reducing off-target effects typical of cysteine-based inhibitors.
Copyright © 2024 Elsevier Ltd. All rights reserved.
MeSH terms
-
Gasdermins
-
Humans
-
Intracellular Signaling Peptides and Proteins* / antagonists & inhibitors
-
Intracellular Signaling Peptides and Proteins* / metabolism
-
Phosphate-Binding Proteins* / antagonists & inhibitors
-
Phosphate-Binding Proteins* / metabolism
-
Pyroptosis* / drug effects
Substances
-
Phosphate-Binding Proteins
-
Intracellular Signaling Peptides and Proteins
-
GSDMD protein, human
-
Gasdermins